PTCT R&D Expenses
Ptc Therapeutics Inc · R&D Expenses
PTCT R&D Expenses
Latest reported$433.31Mperiod ending
PTCT TTM R&D Expenses ($46.14M → $433.31M)
TTM R&D Expenses
High-resolution chart · PNG
PTCT r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 433,308,999 | |
| 447,148,999 | |
| 455,248,999 | |
| 446,891,000 | |
| 508,145,000 | |
| 527,324,000 | |
| 534,480,000 | |
| 531,063,000 | |
| 533,863,000 | |
| 587,568,000 | |
| 666,563,000 | |
| 733,904,000 | |
| 735,154,000 | |
| 706,543,000 | |
| 651,497,000 | |
| 612,647,000 | |
| 578,030,000 | |
| 546,249,000 | |
| 540,684,000 | |
| 508,853,000 | |
| 471,006,000 | |
| 522,049,000 | |
| 477,643,000 | |
| 441,461,000 | |
| 411,539,000 | |
| 294,993,000 | |
| 257,452,000 | |
| 229,268,000 | |
| 220,560,000 | |
| 193,188,000 | |
| 171,985,000 | |
| 147,572,000 | |
| 123,228,000 | |
| 121,456,000 | |
| 117,456,000 | |
| 114,233,000 | |
| 115,605,000 | |
| 113,597,000 | |
| 117,633,000 | |
| 126,670,000 | |
| 125,914,000 | |
| 125,277,000 | |
| 121,816,000 | |
| 113,639,000 | |
| 101,764,000 | |
| 91,887,000 | |
| 79,838,000 | |
| 67,987,029 | |
| 63,108,225 | |
| 59,507,316 | |
| 54,875,144 | |
| 49,305,197 | |
| 45,885,455 | |
| 43,092,364 | |
| 46,138,869 |